Ironwood Pharmaceuticals Reports First Quarter 2019 Results; Announces Positive 2019 Adjusted EBITDA from Continuing Operations Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Ironwood Pharmaceuticals Reports First Quarter 2019 Results; Announces Positive 2019 Adjusted EBITDA from Continuing Operations Guidance

Ironwood Pharma (IRWD) Misses Q1 EPS by 12c

May 2, 2019 7:27 AM EDT

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.26), $0.12 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $68.7 million versus the consensus estimate of $81.18 million.

GUIDANCE:

Ironwood Pharma sees FY2019 revenue of $370-390 million, versus the consensus of... More